Diabetic Kidney Disease Market to Grow at a CAGR of 6% from 2025 to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Diabetic Kidney Disease Market?

The market for diabetic kidney disease has consistently expanded over recent years. It is projected to increase from $2.67 billion in 2024 to $2.8 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 4.8%. Historically, this market expansion has been propelled by factors including an early grasp of diabetes complications, progress in diagnostic techniques, the introduction of ACE inhibitors and ARBs, established clinical trials and treatment protocols, and comprehensive guidelines and disease management protocols.

The market for diabetic kidney disease is projected to experience robust expansion over the coming years. Its value is anticipated to reach $3.53 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 6.0%. Key drivers for this growth during the forecast period include the progress in personalized medicine and biomarker development, an increase in global diabetes prevalence, an emphasis on disease modification therapies, the expansion of telehealth and remote care services, and shifts in healthcare policies and reimbursement structures. Significant trends anticipated in the same period involve innovations in renal replacement therapies, the adoption of a precision medicine approach, a heightened focus on early detection and diagnosis, continuous therapeutic improvements, and an increased emphasis on managing comorbidities.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9932&type=smp

What Are The Top Growth Drivers Impacting The Diabetic Kidney Disease Market Outlook?

The rising prevalence of chronic kidney disease (CKD) is anticipated to propel the growth of the diabetic kidney disease market. Chronic kidney disease is a long-term ailment leading to a gradual loss of kidney function over time, which can result in complications such as high blood pressure, anemia, and bone diseases. The necessity for diagnostic and treatment options for chronic kidney diseases subsequently drives the expansion of the diabetic kidney disease market. For instance, in June 2023, the Kidney Research UK, a prominent UK charity, reported that about 7.2 million people in the United Kingdom are affected by chronic kidney disease, accounting for more than 10% of the population. Among these, 3.25 million are in the most severe stages of the condition, while approximately 3.9 million are in early, often asymptomatic and untreated, stages. Forecasts indicate that the total number of individuals with chronic renal disease in the United Kingdom could reach 7.61 million by 2033. Therefore, the increasing incidence of chronic kidney disease is a key factor driving the growth of the diabetic kidney disease market.

How Is The Diabetic Kidney Disease Market Classified Into Different Segments?

The diabetic kidney diseasemarket covered in this report is segmented –

1) By Type: Type 1 Diabetes; Type 2 Diabetes

2) By Treatment: Angiotensin Receptor Blockers (Arbs); Angiotensin-Converting Enzyme (Ace) Inhibitors; Antioxidant Inflammation Modulator; Calcium Channel Blockers; Other Treatments

3) By End User: Hospitals; Homecare; Specialty Centers; Other End Users

Subsegments:

1) By Type 1 Diabetes: Autoimmune-Related Diabetic Kidney Disease; Early-Onset Diabetic Kidney Disease

2) By Type 2 Diabetes: Obesity-Related Diabetic Kidney Disease; Late-Onset Diabetic Kidney Disease

What Long-Term Trends Will Shape The Future Growth Of The Diabetic Kidney Disease Industry?

Technological progress represents a significant trend gaining traction within the diabetic kidney disease market. Organizations operating in the diabetic kidney disease market are embracing novel technologies to maintain their standing. An illustrative instance occurred in August 2022, when Bloom Diagnostics, a US-based diagnostics and healthcare devices firm, introduced the Bloom Kidney Test, a new instrument capable of integration with the Bloom Smart System. The Bloom Kidney Test functions as a diagnostic instrument designed to evaluate kidney health by assessing cystatin C levels, which serve as a dependable indicator of kidney function. It categorizes kidney function into three distinct levels: normal, mildly decreased, and decreased. The Bloom Smart System utilizes cloud-based algorithms and AI (artificial intelligence) technology to combine test outcomes with other pertinent health data, such as the patient’s medical history, lifestyle, and symptoms.

Who Are The Top Performing Companies In The Diabetic Kidney Disease Market In Recent Years?

Major companies operating in the diabetic kidney disease market include AstraZeneca plc, Pfizer Inc., Novartis AG, Bayer AG, Sanofi SA, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Fresenius SE & Co. KGaA, F. Hoffmann-La Roche AG, Abbott Laboratories, Reata Pharmaceuticals Inc., Merck & Co., Mitsubishi Tanabe Pharma Corporation, Johnson & Johnson pvt. Ltd., Eli Lilly and Company, GlaxoSmithKline plc, AbbVie Inc., Boehringer Ingelheim International GmbH, Chugai Pharmaceutical Co. Ltd., Daiichi Sankyo Company Limited

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Diabetic Kidney Disease Market?

North America was the largest region in the diabetic kidney disease market in 2024. The regions covered in the diabetic kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Diabetic Kidney Disease Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9932&type=smp

Browse Through More Reports Similar to the Global Diabetic Kidney Disease Market 2025, By The Business Research Company

Healthcare Analytical Testing Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/healthcare-analytical-testing-services-global-market-report

Automotive Testing Inspection And Certification Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/automotive-testing-inspection-and-certification-global-market-report

Cold Plasma Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cold-plasma-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795